Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00129597|
Recruitment Status : Unknown
Verified March 2007 by Hospices Civils de Lyon.
Recruitment status was: Active, not recruiting
First Posted : August 12, 2005
Last Update Posted : March 12, 2007
|Condition or disease||Intervention/treatment||Phase|
|Pain Breast Cancer||Drug: ketalar||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy|
|Study Start Date :||December 2004|
- To evaluate the effect of perioperative ketalar on pain intensity 3 months after a mastectomy
- Pain intensity is evaluated by an appropriate questionnaire 1 and 3 months after surgery.
- To evaluate the incidence of chronic pain after mastectomy, the impact on life quality, and the area of hyperalgesia
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00129597
|Centre Hospitalier Lyon Sud|
|Pierre bénite, France, 69495|
|Principal Investigator:||Vincent PIRIOU, MD||Hospices Civils de Lyon|